Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can GoodRx Bounce Back From Its Pandemic Slowdown?


The COVID-19 pandemic produced a growth slowdown at pharmaceutical drug discounter GoodRx Holdings (NASDAQ: GDRX). If patients aren't going to their doctors, they're not going to need drug discounts. The increase in physical distancing also blunted the flu season, which further reduced the need for medications. In this video from Motley Fool Live, recorded on March 15, Fool.com Contributors Brian Orelli and Keith Speights discuss what outside factors could help GoodRx accelerate growth in the quarters to come.

Continue reading


Source Fool.com

Like: 0
Share

Comments